SMO and ameloblastoma: Disruption of the Mitogen-Activated Protein Kinase (MAPK) and Sonic Hedgehog (SHH) signaling pathways, most notably through activating mutations in the BRAF and SMO genes, which are discussed later, appears to play a central role in the pathogenesis and biological behavior of ameloblastoma [14].